Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Breast Neoplasms 69Neoplasms 32Prostatic Neoplasms 30Lung Neoplasms 24Head and Neck Neoplasms 20Neoplasm Metastasis 15Motor Activity 14Colorectal Neoplasms 14Multiple Myeloma 13Ovarian Neoplasms 11Gastrointestinal Neoplasms 11Fatigue 10Carcinoma, Non-Small-Cell Lung 10cyclopia sequence 8Uterine Cervical Neoplasms 8Pancreatic Neoplasms 8Pain 8Lymphoma 8Anxiety Disorders 8Smoking Cessation 7Recurrence 7Neoplasms, Plasma Cell 7Esophageal Neoplasms 7Endometrial Neoplasms 7Carcinoma, Renal Cell 7Tobacco Use Cessation 6Rectal Neoplasms 6Oropharyngeal Neoplasms 6Leukemia 6Depression 6

Interventions

Metformin 3fluorodopa F 18 2Clomiphene 2pasireotide 1dapagliflozin 1amino-acid, glucose, and electrolyte solution 1Surveys and Questionnaires 1Sugars 1Solutions 1Saline Solution 1Pioglitazone 1Insulin 1Injections 1Diazoxide 1Amino Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hyperinsulinism × Surveys and Questionnaires × Clear all
NCT01697566 2025-06-11

An Endometrial Cancer Chemoprevention Study of Metformin

M.D. Anderson Cancer Center

Phase 3 Completed
29 enrolled 12 charts
Other

Hyperinsulinism, Motor Activity, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡